Charter Forecast, price target & analysts
Charter Target price 2026 - Analyst rating & recommendation
Charter Classifications & Recommendation
Charter Price Target
| Target Price | $153.00 |
| Price | $106.96 |
| Potential | 43.04% |
| Number of Estimates | 23 |
| 23 Analysts have issued a price target Charter 2027 . The average Charter target price is $153.00. This is 43.04% higher than the current stock price. The highest price target is $735.00 587.17% , the lowest is $102.01 4.63% . | |
| A rating was issued by 30 analysts: 6 Analysts recommend Charter to buy, 15 to hold and 9 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Charter stock has an average upside potential 2027 of 43.04% . Most analysts recommend the Charter stock at Hold. |
Sales and Margin forecast 2026, 2027 to 2033
25 Analysts have issued a sales forecast Charter 2026 . The average Charter sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an Charter EBITDA forecast 2026. The average Charter EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
26 Charter Analysts have issued a net profit forecast 2026. The average Charter net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
26 Analysts have issued a Charter forecast for earnings per share. The average Charter EPS is
This results in the following potential growth metrics and future valuations:
Current Charter Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 28 2026 |
| Wolfe Research |
Peer Perform
➜
Underperform
|
Downgrade | Sep 14 2026 |
| Morgan Stanley |
➜
Equal-Weight
|
Unchanged | Sep 14 2026 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Jul 29 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Jul 28 2026 |
| RBC Capital |
Sector Perform
➜
Sector Perform
|
Unchanged | Jul 27 2026 |
| Barclays |
Underweight
➜
Underweight
|
Unchanged | Jul 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Sep 28 2026 |
|
Downgrade
Wolfe Research:
Peer Perform
➜
Underperform
|
Sep 14 2026 |
|
Unchanged
Morgan Stanley:
➜
Equal-Weight
|
Sep 14 2026 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Jul 29 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Jul 28 2026 |
|
Unchanged
RBC Capital:
Sector Perform
➜
Sector Perform
|
Jul 27 2026 |
|
Unchanged
Barclays:
Underweight
➜
Underweight
|
Jul 27 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
